Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells

Iliopoulos, Dimitrios, Lindahl-Allen, Marianne, Polytarchou, Christos, Hirsch, Heather A., Tsichlis, Philip N., Struhl, Kevin·2010·Molecular Cell

DOI 10.1016/j.molcel.2010.08.013

Cited by (400)

Items 101–200 of 400

MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells
Paolo Ceppi, Marcus E. Peter · 2013 · Oncogene
Impairment of tumor‐initiating stem‐like property and reversal of epithelial–mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment
Fang‐Wei Hu, Lo‐Lin Tsai, Chuan‐Hang Yu, Pei‐Ni Chen, Ming‐Yung Chou, Cheng‐Chia Yu · 2012 · Molecular Nutrition & Food Research
MicroRNA-mediated breast cancer metastasis: from primary site to distant organs
Li Wang, J Wang · 2011 · Oncogene
Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer
Qin Xu, Qiang Sun, Jianjun Zhang, Jingshuang Yu, Wantao Chen, Zhiyuan Zhang · 2012 · Carcinogenesis
MicroRNA‐494 is a master epigenetic regulator of multiple invasion‐suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors
Kuang‐Hsiang Chuang, Christa L. Whitney‐Miller, Chin‐Yi Chu, Zhongren Zhou, M. Katherine Dokus, Shannon Schmit, Christopher Taylor Barry · 2015 · Hepatology
Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis
Feng Peng, Jianxin Jiang, Yingying Yu, Rui Tian, Xingjun Guo, Xiangnan Li, Ming Shen, Mei Xu, Feng Zhu, Chengjian Shi et al. · 2013 · British Journal of Cancer
Wounds That Will Not Heal
Jung S. Byun, Kevin L Gardner · 2013 · American Journal Of Pathology
The EMT spectrum and therapeutic opportunities
Dominic Chih‐Cheng Voon, Ruby Yun‐Ju Huang, Rebecca A. Jackson, Jean Paul Thiery · 2017 · Molecular Oncology
Epithelial–mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer
Pen‐Yuan Chu, Fang‐Wei Hu, Cheng-Chia Yu, Lo‐Lin Tsai, Chuan-Hang Yu, Buor-Chang Wu, Yi‐Wei Chen, Pin‐I Huang, Wen‐Liang Lo · 2012 · Oral Oncology
Cross Talk between Cancer and Mesenchymal Stem Cells through Extracellular Vesicles Carrying Nucleic Acids
Tatiana Lopatina, Chiara Gai, Maria Chiara Deregibus, Sharad Kholia, Giovanni Camussi · 2016 · Frontiers in Oncology
miR-382 Inhibits Osteosarcoma Metastasis and Relapse by Targeting Y Box-Binding Protein 1
Meng Xu, Hua Jin, Cheng‐Xiong Xu, Bo Sun, Zhigang Song, Wenzhi Bi, Yan Wang · 2014 · Molecular Therapy
Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage
Z Wu, S T Lee, Yuanyuan Qiao, Zhuocheng Li, P L Lee, Y J Lee, Xia Jiang, Jing Ying Tan, Meiyee Aau, Cheryl Zi Hui Lim et al. · 2011 · Cell Death and Differentiation
NDY1/KDM2B Functions as a Master Regulator of Polycomb Complexes and Controls Self-Renewal of Breast Cancer Stem Cells
Filippos Kottakis, Parthena F. Foltopoulou, Ioannis Sanidas, Patricia J. Keller, Ania Wronski, Benjamin T. Dake, Scott A. Ezell, Zhu Shen, Stephen P. Naber, Philip W. Hinds et al. · 2014 · Cancer Research
The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets†
Naomi Pode‐Shakked, Rachel Shukrun, Michal Mark‐Danieli, Peter Tsvetkov, Sarit Bahar, Sara Pri‐Chen, Ronald S. Goldstein, Eithan Rom‐Gross, Yoram Mor, Eddie Fridman et al. · 2012 · EMBO Molecular Medicine
Roles and regulation of tRNA-derived small RNAs in animals
Sowndarya Muthukumar, Cai‐Tao Li, Ru‐Juan Liu, Cristian Bellodi · 2024 · Nature Reviews Molecular Cell Biology
Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells
Kenly Wuputra, Chia‐Chen Ku, Deng‐Chyang Wu, Ying‐Chu Lin, Shigeo Saito, Kazunari K. Yokoyama · 2020 · Journal of Experimental & Clinical Cancer Research
MYC and DNMT 3A‐mediated DNA methylation represses micro RNA ‐200b in triple negative breast cancer
Yamei Pang, Jian Liu, Li Xiang, Guodong Xiao, Huangzhen Wang, Ganghua Yang, Yanbo Li, Shou‐Ching Tang, Sida Qin, Ning Du et al. · 2018 · Journal of Cellular and Molecular Medicine
MiR-205 Dysregulations in Breast Cancer: The Complexity and Opportunities
Yajuan Xiao, Brock A. Humphries, Chengfeng Yang, Zhishan Wang · 2019 · Non-Coding RNA
Review of MiR-200b and cancer chemosensitivity
Bing Feng, Rui Wang, Longbang Chen · 2012 · Biomedicine & Pharmacotherapy
miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer
Erin N. Howe, Dawn R. Cochrane, Diana M. Cittelly, Jennifer K. Richer · 2012 · PLoS ONE
miR‐200c enhances radiosensitivity of human breast cancer cells
Jing Lin, Cong Liu, Fu Gao, R. E. J. Mitchel, Luqian Zhao, Yanyong Yang, Jixiao Lei, Jianming Cai · 2012 · Journal of Cellular Biochemistry
Endometrial miR-200c is Altered During Transformation into Cancerous States and Targets the Expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5
Harekrushna Panda, Leslie Pelakh, Tsai‐Der Chuang, Xiaoping Luo, Orhan Bükülmez, Nasser Chegini · 2012 · Reproductive Sciences
Linking cell signaling and the epigenetic machinery
Helai P. Mohammad, Stephen B. Baylin · 2010 · Nature Biotechnology
Tumor-Suppressing Effects of miR451 in Human Osteosarcoma
Haidong Xu, Qiang Mei, Luxia Shi, Jiajia Lu, Jianning Zhao, Qiang Fu · 2013 · Cell Biochemistry and Biophysics
Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers.
Bin Bao, Asfar Sohail Azmi, Shadan S. Ali, Feras Zaiem, Fazlul H. Sarkar · 2014 · PubMed Central
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
Wei Cao, Jieqing Li, Qiongyu Hao, Jaydutt V. Vadgama, Yong Wu · 2019 · Breast Cancer Research
Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation
Georgios S. Markopoulos, Eugenia Roupakia, Kenneth B. Marcu, Evangelos Kolettas · 2019 · Cells
The Role of MicroRNAs in Breast Cancer Stem Cells
Daniela Schwarzenbacher, Marija Balić, Martin Pichler · 2013 · International Journal of Molecular Sciences
Inhibition of miR-193a Expression by Max and RXRα Activates K-Ras and PLAU to Mediate Distinct Aspects of Cellular Transformation
Dimitrios Iliopoulos, Asaf Rotem, Kevin Struhl · 2011 · Cancer Research
Stem Cells and Cellular Origins of Breast Cancer: Updates in the Rationale, Controversies, and Therapeutic Implications
Jiaojiao Zhou, Qishan Chen, Yiheng Zou, Huihui Chen, Lina Qi, Yiding Chen · 2019 · Frontiers in Oncology
The proto-oncogene KRAS is targeted by miR-200c
Florian B. Kopp, Ernst Wagner, Andreas Roidl · 2013 · Oncotarget
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells
Ilaria Dando, Marco Cordani, Elisa Dalla Pozza, Giulia Biondani, Massimo Donadelli, Marta Palmieri · 2015 · Oxidative Medicine and Cellular Longevity
MicroRNAs involved in regulating epithelial–mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics
Hongping Xia, Kam Man Hui · 2012 · Cancer Gene Therapy
Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury
Tae Jin Lee, Xiaoyi Yuan, Keith M. Kerr, Ji Young Yoo, Dong Kim, Balveen Kaur, Holger K. Eltzschig · 2020 · Pharmacological Reviews
Expression and clinicopathological significance of EED, SUZ12 and EZH2 mRNA in colorectal cancer
Yanlong Liu, Xu Gao, Yang Jiang, Gan Zhang, Zicheng Sun, Binbin Cui, Yanmei Yang · 2014 · Journal of Cancer Research and Clinical Oncology
SUZ12 Promotes Human Epithelial Ovarian Cancer by Suppressing Apoptosis via Silencing HRK
Hua Li, Qi K. Cai, Hong Gyun Wu, Vinod Vathipadiekal, Zachary C. Dobbin, Tianyu Li, Hua Xiang, Charles N. Landen, Michael J. Birrer, Margarita Sánchez‐Beato et al. · 2012 · Molecular Cancer Research
MicroRNAs in breast cancer initiation and progression
Huiping Liu · 2012 · Cellular and Molecular Life Sciences
MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment
Nirav R. Shah · 2014 · World Journal of Clinical Oncology
miR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/β-Catenin Signaling
Hua Jin, Song Luo, Yun Wang, Chang Liu, Zheng-Hao Piao, Meng Xu, Wei Guan, Qing Li, Hua Zou, Qun-You Tan et al. · 2017 · Molecular Therapy — Nucleic Acids
Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a
Jessica Finlay-Schultz, Diana M. Cittelly, P Hendricks, P Patel, Peter Kabos, Britta M. Jacobsen, Jennifer K. Richer, Carol A. Sartorius · 2014 · Oncogene
Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis
Shuet Theng Lee, Min Feng, Yong Wei, Zhimei Li, Yuanyuan Qiao, Peiyong Guan, Xia Jiang, Chew Hooi Wong, Kelly T. Huynh, Jinhua Wang et al. · 2013 · Proceedings of the National Academy of Sciences
IMP2 and IMP3 cooperate to promote the metastasis of triple-negative breast cancer through destabilization of progesterone receptor
Kim, Hye-Youn, Ha Thi, Huyen Trang, Hong, Suntaek · 2018 · Cancer Letters
MicroRNA Regulation of Epigenetic Modifiers in Breast Cancer
Brock A. Humphries, Zhishan Wang, Chengfeng Yang · 2019 · Cancers
An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription
Emily C. Knouf, Kavita S. Garg, Jason D. Arroyo, Yesenia Correa, Deepayan Sarkar, Rachael K. Parkin, Kaitlyn Wurz, Kathy C. O'Briant, Andrew K. Godwin, Nicole D. Urban et al. · 2011 · Nucleic Acids Research
MiR‐200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1
Yasai Yao, JIAN LI HU, Zan Shen, Ruyong Yao, ShiHai Liu, Yong Li, Hui Cong, Xingang Wang, Wensheng Qiu, Lu Yue · 2015 · Journal of Cellular and Molecular Medicine
Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma–derived side population cancer stem cells
Cheng‐Chia Yu, Fang‐Wei Hu, Chuan‐Hang Yu, Ming‐Yung Chou · 2014 · Head & Neck
Downregulation of miR-200a Induces EMT Phenotypes and CSC-like Signatures through Targeting the β-catenin Pathway in Hepatic Oval Cells
Jie Liu, Bai Ruan, Nan You, Qike Huang, Weihui Liu, Zheng Dang, Weihua Xu, Ti Zhou, Ru Ji, Yang Cao et al. · 2013 · PLoS ONE
The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
Getinet Mequanint Adinew, Equar Taka, Patricia Mendonca, Samia S. Messeha, Karam F. A. Soliman · 2021 · Nutrients
From microRNAs to targets: pathway discovery in cell fate transitions
Deepa Subramanyam, Robert H. Blelloch · 2011 · Current Opinion in Genetics & Development
MicroRNA control of epithelial‐mesenchymal transition in cancer stem cells
Jin Hao, Yueling Zhang, Meng‐Zhao Deng, Rui Ye, Sen Zhao, Yating Wang, Juan Li, Zhihe Zhao · 2014 · International Journal of Cancer
MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
Hua Shen, Lin Wang, Xin Quan Ge, Chengfei Jiang, Zhumei Shi, Dongmei Li, Weitao Liu, Xiaobo Yu, Yongqian Shu · 2016 · Oncotarget
Adherens Junctions and Cancer
Valeri I. Vasioukhin · 2012 · Sub-cellular biochemistry/Subcellular biochemistry
Tamoxifen Represses miR-200 MicroRNAs and Promotes Epithelial-to-Mesenchymal Transition by Up-Regulating c-Myc in Endometrial Carcinoma Cell Lines
Jiuxu Bai, Bo Yan, Zhining Zhao, Xiao Xiao, Weiwei Qin, Rui Zhang, Lintao Jia, Yan–Ling Meng, Boquan Jin, Daiming Fan et al. · 2013 · Endocrinology
MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development
Lu Deng, Shang Li, Shoumin Bai, Ji Chen, Xueyan He, Rachel Martin-Trevino, Shanshan Chen, Xiaoyan Li, Xiaojie Meng, Bin Yu et al. · 2014 · Cancer Research
Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression
Thomas J. Rogers, Jessica L. Christenson, Lisa I. Greene, Kathleen I. O’Neill, Michelle M. Williams, Melita A. Gordon, Travis G. Nemkov, Angelo D’Alessandro, Greg D. Degala, Jimin Shin et al. · 2018 · Molecular Cancer Research
Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment
Bing Cheng Feng, Kai Zhang, Rui Wang, Longbang Chen · 2015 · Clinical Science
Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2
Stephen G. Dann, Michael Ryskin, Anthony M. Barsotti, Jonathon Golas, Celine Shi, Miriam Miranda, Christine Hosselet, LuAnna Lemon, Judy Lucas, Maha Karnoub et al. · 2015 · The EMBO Journal
MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer
Eylem Aydoğdu, Anne Katchy, Efrosini Tsouko, Chin‐Yo Lin, Lars-Arne Haldosén, Luisa Alejandra Helguero, Cecilia Williams · 2012 · Carcinogenesis
A role for partial epithelial-to-mesenchymal transition in enabling stemness in homeostasis and cancer
Jeroen Verstappe, Geert Berx · 2023 · Seminars in Cancer Biology
miR-449b inhibits the proliferation of SW1116 colon cancer stem cells through downregulation of CCND1 and E2F3 expression
Yantian Fang, Xiaodong Gu, Zhengyang Li, Jianbin Xiang, Zongyou Chen · 2013 · Oncology Reports
Role of p38γ MAPK in regulation of EMT and cancer stem cells
Mei Xu, Siying Wang, Yongchao Wang, Huaxun Wu, Jacqueline A. Frank, Zhuo Zhang, Jia Luo · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Compensatory Function of Pyk2 Protein in the Promotion of Focal Adhesion Kinase (FAK)-null Mammary Cancer Stem Cell Tumorigenicity and Metastatic Activity
Huaping Fan, Jun‐Lin Guan · 2011 · Journal of Biological Chemistry
Epigenetic programming of hypoxic–ischemic encephalopathy in response to fetal hypoxia
Qingyi Ma, Li Zhang · 2014 · Progress in Neurobiology
lnflammation-induced epigenetic switches in cancer
Matjaž Rokavec, Meryem Gülfem Öner, Heiko Hermeking · 2015 · Cellular and Molecular Life Sciences
The Emerging Role of miR-200 Family in Cardiovascular Diseases
Alessandra Magenta, Roberta Ciarapica, Maurizio Colognesi Capogrossi · 2017 · Circulation Research
MicroRNAs: Diverse Mechanisms of Action and Their Potential Applications as Cancer Epi-Therapeutics
Anna Sadakierska−Chudy · 2020 · Biomolecules
Regulating Methylation at H3K27: A Trick or Treat for Cancer Cell Plasticity
Provas Das, Joseph H. Taube · 2020 · Cancers
HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells
Dongqin Chen, Banzhou Pan, Jiayuan Huang, Kai Zhang, Shi-Yun Cui, Wei De, Rui Wang, Longbang Chen · 2014 · Oncotarget
Non-coding RNAs related to angiogenesis in gynecological cancer
Neda Rahimian, Zahra Sadat Razavi, Fatemeh Aslanbeigi, Amir Masoud Mirkhabbaz, Haleh Piroozmand, Mohammad Karim Shahrzad, Michael Richard Hamblin, Hamed Mirzaei · 2021 · Gynecologic Oncology
Expression of microRNAs: potential molecular link between obesity, diabetes and cancer
Ashhar S. Ali, Shafat Ali, Aamir Ahmad, Bin Bao, P. A. Philip, Fazlul H. Sarkar · 2011 · Obesity Reviews
miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2
Haifeng Zhang, Kai Zhang, Lian‐Di Liao, Liyan Li, Zepeng Du, Bingli Wu, Jian‐Yi Wu, Xiu‐E Xu, Fa‐Min Zeng, Bo Chen et al. · 2013 · Carcinogenesis
Targeting CSCs in Tumor Microenvironment: The Potential Role of ROS-Associated miRNAs in Tumor Aggressiveness
Bin Bao, Asfar Sohail Azmi, Yiwei Li, Aamir Ahmad, Shadan S. Ali, Sanjeev Banerjee, Dejuan Kong, Fazlul H. Sarkar · 2013 · Current Stem Cell Research & Therapy
Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance
Ainaz Mihanfar, Javad Aghazadeh-Attari, Iraj Mohebbi, Maryam Majidinia, Mojtaba Kaviani, Mehdi Yousefi, Bahman Yousefi · 2018 · Journal of Cellular Physiology
Molecular mechanisms controlling asymmetric and symmetric self-renewal of cancer stem cells
Young Dong Yoo, Yong Tae Kwon · 2015 · Journal of Analytical Science & Technology
MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma
Zehang Zhuang, Pei Yu, Nan Xie, Yue Wu, Haichao Liu, Ming Zhang, Yifan Tao, Weiwang Wang, Hanqi Yin, Bin Zou et al. · 2020 · Theranostics
On the epigenetic origin of cancer stem cells
Audrey Vincent, Isabelle VAN SEUNINGEN · 2012 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
c-MYC–miRNA circuitry
Jiangchuan Tao, Xiaohong Zhao, Jianguo Tao · 2014 · Cell Cycle
Loss of Mel‐18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway
Hee‐Young Won, Jeong‐Yeon Lee, Dong‐Hui Shin, Ji‐Hye Park, Jeong‐Seok Nam, Hyoung‐Chin Kim, Gu Kong · 2012 · The FASEB Journal
How microRNAs facilitate reprogramming to pluripotency
Frederick Anokye-Danso, Melinda E. Snitow, E. Morrisey · 2012 · Journal of Cell Science
SUZ12 is involved in progression of non-small cell lung cancer by promoting cell proliferation and metastasis
Chunhua Liu, Xuefei Shi, Li Wang, Ying Wu, Feiyan Jin, Cuiqing Bai, Yong Song · 2014 · Tumor Biology
MicroRNAs: Biogenesis, Roles for Carcinogenesis and as Potential Biomarkers for Cancer Diagnosis and Prognosis
Nowroji Kavitha, Soundararajan Vijayarathna, Subramanion Lachumy Jothy, Chern Ein Oon, Yeng Chen, Jagat R. Kanwar, Sreenivasan Sasidharan · 2014 · Asian Pacific Journal of Cancer Prevention
miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1
Jipeng Li, Shanfeng Li, Zhe Chen, Jian‐Hua Wang, Ying Chen, Zhengyang Xu, Mingwei Jin, Wanjun Yu · 2016 · Tumor Biology
Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
Sangita Sridharan, Cory M. Howard, Augustus M. C. Tilley, Boopathi Subramaniyan, Amit Kumar Tiwari, Randall J. Ruch, Dayanidhi Raman · 2019 · Frontiers in Oncology
The role of non-coding RNAs in the regulation of stem cells and progenitors in the normal mammary gland and in breast tumors
Chiara Tordonato, Pier Paolo Di Fiore, Francesco Nicassio · 2015 · Frontiers in Genetics
Role of microRNA-138 as a Potential Tumor Suppressor in Head and Neck Squamous Cell Carcinoma
Yi Jin, Dan Chen, Robert J. Cabay, Anxun Wang, David L. Crowe, Xiaofeng C. Zhou · 2013 · International review of cytology
Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein
Leo L. Studach, Stephan Menne, Stefano Cairo, Marie Annick Buendia, Ronald Loral Hullinger, Lydie Lefrançois, Philippe Merle, OURANIA M. ANDRISANI · 2012 · Hepatology
miR-200b targets GATA-4 during cell growth and differentiation
Chun-Xia Yao, Qing-Xia Wei, Yanyan Zhang, Wei-Ping Wang, Lixiang Xue, Fen Yang, Shufeng Zhang, Cheng-Juan Xiong, Wenyan Li, Zhiru Wei et al. · 2013 · RNA Biology
SUZ12 promotes gastric cancer cell proliferation and metastasis by regulating KLF2 and E-cadherin
Rui Xia, Fei-yan Jin, Kai Lǚ, Li Wan, Min Xie, Tongpeng Xu, Wei De, Zhao-xia Wang · 2015 · Tumor Biology
The Functional Role of SEC23 in Vesicle Transportation, Autophagy and Cancer
Jingchen Jing, Bo Wang, Peijun Liu · 2019 · International Journal of Biological Sciences
miR-200c at the nexus of epithelial-mesenchymal transition, resistance to apoptosis, and the breast cancer stem cell phenotype
Derek C. Radisky · 2011 · Breast Cancer Research
YC ‐1 inhibits proliferation of breast cancer cells by down‐regulating EZH 2 expression via activation of c‐ C bl and ERK
Ling‐Chu Chang, Hui‐Yi Lin, Meng‐Tung Tsai, Ruey‐Hwang Chou, Fang‐Yu Lee, Che‐Ming Teng, Min‐Tsang Hsieh, Hsin‐Yi Hung, Li‐Jiau Huang, Yung‐Luen Yu et al. · 2014 · British Journal of Pharmacology
Regulation of miRNA Processing and miRNA Mediated Gene Repression in Cancer
Sarah Bajan, György Hutvágner · 2014 · MicroRNA
Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells
Yannick D. Benoit, Mavee Witherspoon, Kristian Bruun Laursen, Amel Guezguez, Marco Beauséjour, Jean‐François Beaulieu, Steven M. Lipkin, Lorraine J. Gudas · 2013 · Experimental Cell Research
Targeting CSC-Related miRNAs for Cancer Therapy by Natural Agents
Bin Bao, Yiwei Li, Aamir Ahmad, Asfar Sohail Azmi, Ginny W. Bao, Shadan S. Ali, Sanjeev Banerjee, Dejuan Kong, Fazlul H. Sarkar · 2012 · Current Drug Targets
Inhibition of PRC2 histone methyltransferase activity increases TRAIL‐mediated apoptosis sensitivity in human colon cancer cells
Yannick D. Benoit, Kristian Bruun Laursen, Mavee Witherspoon, Steven M. Lipkin, Lorraine J. Gudas · 2012 · Journal of Cellular Physiology
Concise Review: Breast Cancer Stem Cells: Regulatory Networks, Stem Cell Niches, and Disease Relevance
Wenjun Guo · 2014 · Stem Cells Translational Medicine
microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu)
Haixia Long, Zhongyu Wang, Junying Chen, Tong Xiang, Qijing Li, Xinwei Diao, Bo Zhu · 2015 · Oncotarget
The miR‐200b–ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma
Shu‐Chun Tsai, Chen‐Chun Lin, Tsung‐Chieh Shih, R.-Y. Tseng, Ming‐Chin Yu, Yu‐Jr Lin, Sen‐Yung Hsieh · 2017 · Molecular Carcinogenesis
Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells
Bin Bao, Aamir Ahmad, Yiwei Li, Asfar Sohail Azmi, Shadan S. Ali, Sanjeev Banerjee, Dejuan Kong, Fazlul H. Sarkar · 2012 · Expert Opinion on Therapeutic Targets
A Polycomb-mir200 loop regulates clinical outcome in bladder cancer
Mónica Martínez‐Fernández, Marta Dueñas, Andrew Feber, Cristina Segovia, Ramón García‐Escudero, Carolina Rubio, Fernando López-Calderón, C. Vanesa Díaz-García, Felipe Villacampa, José Manuel Duarte et al. · 2015 · Oncotarget